{"name":"Merz Pharmaceuticals GmbH","slug":"merz-pharmaceuticals-gmbh","ticker":"","exchange":"","domain":"merzgmbh.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Hyaluronic acid filler/IMD1 basic","genericName":"Hyaluronic acid filler/IMD1 basic","slug":"hyaluronic-acid-filler-imd1-basic","indication":"Facial wrinkles and folds correction","status":"marketed"},{"name":"Contractubex","genericName":"Contractubex","slug":"contractubex","indication":"Other","status":"marketed"},{"name":"IncobotulinumtoxinA (75 Units)","genericName":"IncobotulinumtoxinA (75 Units)","slug":"incobotulinumtoxina-75-units","indication":"Cervical dystonia","status":"phase_3"},{"name":"OnabotulinumtoxinA (Vistabel®)","genericName":"OnabotulinumtoxinA (Vistabel®)","slug":"onabotulinumtoxina-vistabel","indication":"Blepharospasm","status":"phase_3"},{"name":"Pantovigar","genericName":"Pantovigar","slug":"pantovigar","indication":"Other","status":"phase_2"},{"name":"incobotulinumtoxinA (Xeomin)","genericName":"incobotulinumtoxinA (Xeomin)","slug":"incobotulinumtoxina-xeomin","indication":"Blepharospasm","status":"phase_3"}]}],"pipeline":[{"name":"Hyaluronic acid filler/IMD1 basic","genericName":"Hyaluronic acid filler/IMD1 basic","slug":"hyaluronic-acid-filler-imd1-basic","phase":"marketed","mechanism":"Hyaluronic acid filler provides volumization and hydration to facial tissues by integrating into the dermis and binding water molecules.","indications":["Facial wrinkles and folds correction","Lip augmentation","Facial volume restoration"],"catalyst":""},{"name":"Contractubex","genericName":"Contractubex","slug":"contractubex","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IncobotulinumtoxinA (75 Units)","genericName":"IncobotulinumtoxinA (75 Units)","slug":"incobotulinumtoxina-75-units","phase":"phase_3","mechanism":"IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Hemifacial spasm","Glabellar lines (dynamic wrinkles)","Crow's feet"],"catalyst":""},{"name":"OnabotulinumtoxinA (Vistabel®)","genericName":"OnabotulinumtoxinA (Vistabel®)","slug":"onabotulinumtoxina-vistabel","phase":"phase_3","mechanism":"OnabotulinumtoxinA works by temporarily paralyzing muscles to treat various conditions.","indications":["Blepharospasm","Cervical dystonia","Focal spasticity","Hemifacial spasm","Severe primary axillary hyperhidrosis"],"catalyst":""},{"name":"Pantovigar","genericName":"Pantovigar","slug":"pantovigar","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"incobotulinumtoxinA (Xeomin)","genericName":"incobotulinumtoxinA (Xeomin)","slug":"incobotulinumtoxina-xeomin","phase":"phase_3","mechanism":"IncobotulinumtoxinA is a botulinum toxin type A that works by blocking the release of acetylcholine, a neurotransmitter that causes muscle contractions.","indications":["Blepharospasm","Cervical dystonia","Strabismus","Spasticity","Hemifacial spasm"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"regulatory","source":"EIN News","summary":"Hyaluronic Acid-Based Dermal Fillers Market 2026 growing due to rising demand for aesthetic treatments - EIN News","headline":"Hyaluronic Acid-Based Dermal Fillers Market 2026 growing due to rising demand for aesthetic treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPYjdFelBfN0FrcWRpdlo0LWQ1UHdtclhXWXZqOGdnUXd1VTFJbDBvR0QyRGlFcWJPcFk4Z2pzc3piNkV2eWo5QWxjckdQbFUxX1ozVURsU19uQmZMZEh1MG1YQmtEclR3TGZ5VmhGYUpFQXpsdlcyU2lCemk4TFR6MGxyQkt4S0QxakczcDRsTGNxeUJ5UkhDU3dFR1puSVdhbUFOa2xycw?oc=5","date":"2026-02-10","type":"deal","source":"CSRwire","summary":"Merz Aesthetics Extends Partnership With North Carolina Women’s Soccer Team - CSRwire","headline":"Merz Aesthetics Extends Partnership With North Carolina Women’s Soccer Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOVElkdE1HNmQ3am1VaXBsZnlScjBucE1rRGdPOTN3LTVKcWFmNUJvTjNfRTR5N1JPUUtlSGUzLW1zZmxCb2lNUXZNSHhrQ1JwNHNuZENLdnVfV1FzU1ZaT3g0ZE56R0t1dEpIcHpDbHNNMEl4YVdxdmpOMi1XRDdySUc1Rk5Xb2dBaVRXUU00Sldoa3NlbThkR1BBbVl3SnpRM0xmWThDa0FRUU93bk9tcjRkR3laNTJ6RmdaY0pxSUprY3M1MWh4Y0VLbHNSVmJIV1pvSjU4VkNqajc3WDktbVdtTkFpdw?oc=5","date":"2025-12-16","type":"pipeline","source":"Business Wire","summary":"Merz Aesthetics® Launches XEOMIN® and RADIESSE® in China, Expands Presence in Key Strategic Market - Business Wire","headline":"Merz Aesthetics® Launches XEOMIN® and RADIESSE® in China, Expands Presence in Key Strategic Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOR0I0Zm1ZVTR1ZnVGalNRVkJHOWpwRzAtTGNsRXV3YjVTVHRuV0E1YjgyczVaZnpDMEVPYjQ4aHpsMXlRVHBhU1NqaHZYLXF0d0NUSWlaeGZOZS15VDhfaEFFSjBKdjVTNmc3VTFtY1Rmdll6Si1BaHZwMWVOY1JlZzd2NUlLZE5VYWNBTXo4bTFWNFpLVEVybDJkY180aVpBYTZjQ2tuY0tjY2tjQVhVVVpNRHNpNkp6dmlvcURWVk9KcTJSMTJzRkdiZlNzREs1by1OM3ZyVmpRY2dTNkloeWR4MWFqZnRpVFpkeE0tVEY0SkF3OGdxR2k3UDZiZHU3bmxVWTZPVk5MNUN6RGtoT0VZSVVTQ0RUeHFWdVhHbGY?oc=5","date":"2025-11-05","type":"regulatory","source":"Business Wire","summary":"Merz Aesthetics® Announces New Arms and Abdomen* Indication for Ultherapy PRIME, the Only FDA-Cleared Ultrasound With Real-Time Visualization - Business Wire","headline":"Merz Aesthetics® Announces New Arms and Abdomen* Indication for Ultherapy PRIME, the Only FDA-Cleared Ultrasound With Re","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPczJDZ25jZG1wMmJRXzdZSXFjNlh3REtDMktTUHdGQ25WYWRYcnpvVjJUYlo3V3FXdzF5dGtBVXlZNlFRQlV0bHRVYjVNdzlvcmpKR3VoendQSkRyNm9ZZjFONFV6NHZaWUpnZi1BdUxEYVM4dEZDVUNhWkpoTXI1YzAzcGpKazE3S1BXbG5VVXhzV1VWQ1VPYVNuSmtrTVNzQ3ZPU05XdHBKUE5idVlFM2xfV2RnbTg0R21PT3FJb05mX3FJcW1OX1BJTUphXzRQOC04MXViU1VIdUkxWGl0cnN2LWdFYndXYUotVg?oc=5","date":"2025-10-28","type":"pipeline","source":"Business Wire","summary":"Merz Group Expands Management Board: Dr. Almuth Steinkühler Appointed New Chief Financial Officer (CFO) - Business Wire","headline":"Merz Group Expands Management Board: Dr. Almuth Steinkühler Appointed New Chief Financial Officer (CFO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQVTdNVVJjdFN4aUNCSW9ZaHVKbDhPNUZ6TzVpMm1VV282RFJwdjZRZlQ2ZHZLVmRhRkhLajktMFowUWJZYmtQS0FOWkZpSnA4R1QxNVFlNXBaVVFueVB1dV80dXhycmFvVWE0Wm90WjEyZG1VamU5WkpCWVlXWFhoWmU1ZHZTUGw4OWc0MGRVMk5veWcwWjVhYWhKMC0xaTJHY1dYd21VV1NKbExS?oc=5","date":"2025-08-11","type":"patent","source":"JUVE Patent","summary":"Carpmaels and A&O Shearman file first SPC suit at UPC for Merz against Viatris - JUVE Patent","headline":"Carpmaels and A&O Shearman file first SPC suit at UPC for Merz against Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxONUNmaTVVOEVCaGdYSmpkdGVxcjFLZWs1Tmt2U3ozcmlkYVZsUkxaaXBnT3hmMFpBVzJxbU45QjVYOUZTeXVxUloxdG1sM2FUdTliRHZBa2M5N0NsTGsyaDJYNXZ1a2ZKNnBaWUx3c285MEgyYzN6cWNocGN6RzNOS3lpMWgtdzZJZ1JJSDBpRUJkUzU3V2g5MURfVW1adnZIT1gta1hudGR0NjlxS3FZREZlamE5VUExMEpNXzRLSEgyS0k3S0lJeXRBZGRPS1FxTGpyTUpVbXUzR1BJYndsX19uTQ?oc=5","date":"2025-01-23","type":"pipeline","source":"Business Wire","summary":"Merz Aesthetics® Launches Ultherapy PRIME® in the EMEA Region at the 2025 IMCAS World Congress - Business Wire","headline":"Merz Aesthetics® Launches Ultherapy PRIME® in the EMEA Region at the 2025 IMCAS World Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxPcmRlLXJwMDJDYTR5ejhyU053ZHlWRkI5ckMyaFEtWXRMTWROcDJSM29fY0wtMVNRZjZuZFFObGtObE51NHZuUE1KZ2l5Y1lZb2pTdmNaVzl2N3B6cWhYa3BrVjd6dEFITlRweDFCb3NVQzc0c1ZMM3V4WjlHWlpZLVlzNUNZOVRBUWxJbVBhaGhUaC01b2UySW8yLTVjMWZBMkhmSlpNbE5lMnd0ZUw4cEVJZFhoWm4xQnZDcWpQaERvODVOR0JnWjZ4UklpbGxwci1LcmY1THFPUEtLMU5ZZmZsRldkNkJfZVlaRDlsQjNnaU9OaVdsc3Q0cGRiX2NhZEJuWg?oc=5","date":"2024-12-17","type":"regulatory","source":"BioSpace","summary":"Health Canada Approves XEOMIN® (incobotulinumtoxinA) for Treatment of Adults with Post-stroke Lower Limb Spasticity in the Ankle and Foot - BioSpace","headline":"Health Canada Approves XEOMIN® (incobotulinumtoxinA) for Treatment of Adults with Post-stroke Lower Limb Spasticity in t","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQdjdNZmlWb0hfYjhwM2JsZjBlaFRYM3UzdlFqRE5PanlXZ0FvT25OMEtHdnlxN3dBVkUxRy1ScXRlbEsxY3owX3RsT3J6TUxHdENEcEM0ZTluUHlUcjQtd29mdWFwbXVMYTRqOHp5anlvOExXdWlKdVlRcHRuVlo2LU1udlMyUEZ2TWNCTV81NWViTHdyNTdNZHpn?oc=5","date":"2024-11-14","type":"regulatory","source":"Fierce Pharma","summary":"FDA slams Merz over 'misleading' Instagram ad for Botox rival - Fierce Pharma","headline":"FDA slams Merz over 'misleading' Instagram ad for Botox rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUGtZNldMbVhhT2J1NVdxbXNNTlZuSnpnc2djai1QTERJcWw1RU9BYjJybElQb3ZGU3plcXMweHM5NGJ0MUd0QXI0S213Ync0MUZra3A0WGtwemdpaWNMWG9IdklwMVZNWjJscjV3Uk41XzdKck5VZE9fTUhHTGlVMm5lWlVzUHFmSl9EWU04blo0MHRGTXdfSFR3ckZCLXFsa1E?oc=5","date":"2024-04-02","type":"pipeline","source":"The Business Journals","summary":"Merz offers $185 million for assets of bankrupt biotech - The Business Journals","headline":"Merz offers $185 million for assets of bankrupt biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdE53MVRyckVVNF8za1BHeC1ITkpnMHhoTG5OYWRMR1BzaEJtaWUwd1VvbDZNdWxPejgxdklScERzUTF1ZmZ3bUtHV1drOEFQb0xjcmNYZ0RpU1ZYazFESU5RQ3RoamFIdVEzVHNkSkxBTDlLWEtOQ0RVV0k0MUNzQlhyeWlKVTU0Q3ZMYzN5NlZXZHdCVTB3Wm5fLS1yUTg?oc=5","date":"2023-03-01","type":"pipeline","source":"Business Wire","summary":"New CEO for Merz Therapeutics: Stefan König - Business Wire","headline":"New CEO for Merz Therapeutics: Stefan König","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxORlFMY2dETkw4RmpqNmRCSWlnYWdjNDZxMmExd2k5Vy1JRGMxTnBlR0tkUGEtb05PdlF6Q04wNGZFWTBZaXJlUWpJeVotS3Z6VHJZYk5PRFNFVzdvM1ROLU1yR3d3eG1hdDRDdUgxRDFaSjZZYUFhdmlhOEJCUjFzSjVZakw4RU1BWnZIa0NYdTlHaXZ3aW53cmFNYWRNVWtvQmRFTkVwNzdyRTRGOGl3MHpaSEpHdmo2OUxOQldMc0N2UQ?oc=5","date":"2021-08-11","type":"deal","source":"BioSpace","summary":"Merz and Israeli Start-Up Vensica Launch Partnership for Needleless Treatment of Overactive Bladder - BioSpace","headline":"Merz and Israeli Start-Up Vensica Launch Partnership for Needleless Treatment of Overactive Bladder","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":2,"phase_3":3,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}